A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity

Por Sargent, Jennifer L., Milano, Ausra, Bhattacharyya, Swati, Varga, John, Connolly, M. Kari, Chang, Howard Y., Whitfield, Michael L.
Publicado em 2009

Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin

Por Milano, Ausra, Pendergrass, Sarah A., Sargent, Jennifer L., George, Lacy K., McCalmont, Timothy H., Connolly, M. Kari, Whitfield, Michael L.
Publicado em 2008

Correction: Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin

Por Milano, Ausra, Pendergrass, Sarah A., Sargent, Jennifer L., George, Lacy K., McCalmont, Timothy H., Connolly, M. Kari, Whitfield, Michael L.
Publicado em 2008

Whole Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis

Por Mak, Angel CY, Tang, Paul LF, Cleveland, Clare, Smith, Melanie H, Connolly, M Kari, Katsumoto, Tamiko R, Wolters, Paul J, Kwok, Pui-Yan, Criswell, Lindsey A
Publicado no Arthritis Rheumatol (2016)

Spectrum of immune-related conditions associated with risk of keratinocyte cancers among elderly adults in the United States

Por Yanik, Elizabeth L., Pfeiffer, Ruth M., Freedman, D. Michal, Weinstock, Martin A., Cahoon, Elizabeth K., Arron, Sarah T., Chaloux, Matthew, Connolly, M. Kari, Nagarajan, Priyadharsini, Engels, Eric A.
Publicado no Cancer Epidemiol Biomarkers Prev (2017)

Systemic and cell type-specific gene expression patterns in scleroderma skin

Por Whitfield, Michael L., Finlay, Deborah R., Murray, John Isaac, Troyanskaya, Olga G., Chi, Jen-Tsan, Pergamenschikov, Alexander, McCalmont, Timothy H., Brown, Patrick O., Botstein, David, Connolly, M. Kari
Publicado em 2003

Outcomes in Systemic Sclerosis-related Lung Disease following Lung Transplantation

Por Sottile, Peter D, Iturbe, David, Katsumoto, Tamiko R, Connolly, M Kari, Collard, Harold R, Leard, Lorriana A, Hays, Steven, Golden, Jeffrey A, Hoopes, Charles, Kukreja, Jasleen, Singer, Jonathan P
Publicado em 2013

Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM

Por Goreshi, Renato, Okawa, Joyce, Rose, Matt, Feng, Rui, Lee, Lela A., Hansen, Christopher, Bangert, Carolyn, Connolly, M. Kari, Davis, Mark, Callen, Jeff P., Fett, Nicole, Fakharzadeh, Steven, Clarke, Jennie, Werth, Victoria P.
Publicado em 2012

Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis

Por Chung, Lorinda, Fiorentino, David F., Benbarak, Maya J., Adler, Adam S., Mariano, Melissa M., Paniagua, Ricardo T., Milano, Ausra, Connolly, M. Kari, Ratiner, Boris D., Wiskocil, Robert L., Whitfield, Michael L., Chang, Howard Y., Robinson, William H.
Publicado em 2009

Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

Por Fleming, Jo N., Nash, Richard A., McLeod, D. O., Fiorentino, David F., Shulman, Howard M., Connolly, M. Kari, Molitor, Jerry A., Henstorf, Gretchen, Lafyatis, Robert, Pritchard, David K., Adams, Lawrence D., Furst, Daniel E., Schwartz, Stephen M.
Publicado em 2008

Correction: Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

Por Fleming, Jo N., Nash, Richard A., McLeod, D. O., Fiorentino, David F., Shulman, Howard M., Connolly, M. Kari, Molitor, Jerry A., Henstorf, Gretchen, Lafyatis, Robert, Pritchard, David K., Adams, Lawrence D., Furst, Daniel E., Schwartz, Stephen M.
Publicado em 2008

Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

Por Tashkin, Donald P., Elashoff, Robert, Clements, Philip J., Roth, Michael D., Furst, Daniel E., Silver, Richard M., Goldin, Jonathan, Arriola, Edgar, Strange, Charlie, Bolster, Marcy B., Seibold, James R., Riley, David J., Hsu, Vivien M., Varga, John, Schraufnagel, Dean, Theodore, Arthur, Simms, Robert, Wise, Robert, Wigley, Fred, White, Barbara, Steen, Virginia, Read, Charles, Mayes, Maureen, Parsley, Ed, Mubarak, Kamal, Connolly, M. Kari, Golden, Jeffrey, Olman, Mitchell, Fessler, Barri, Rothfield, Naomi, Metersky, Mark, Khanna, Dinesh, Li, Ning, Li, Gang
Publicado em 2007

Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised...

Por Tashkin, Donald P, Roth, Michael D, Clements, Philip J, Furst, Daniel E, Khanna, Dinesh, Kleerup, Eric C, Goldin, Jonathan, Arriola, Edgar, Volkmann, Elizabeth R, Kafaja, Suzanne, Silver, Richard, Steen, Virginia, Strange, Charlie, Wise, Robert, Wigley, Fredrick, Mayes, Maureen, Riley, David J, Hussain, Sabiha, Assassi, Shervin, Hsu, Vivien M, Patel, Bela, Phillips, Kristine, Martinez, Fernando, Golden, Jeffrey, Connolly, M Kari, Varga, John, Dematte, Jane, Hinchcliff, Monique, Fischer, Aryeh, Swigris, Jeffrey, Meehan, Richard, Theodore, Arthur, Simms, Robert, Volkov, Suncica, Schraufnagel, Dean E, Scholand, Mary Beth, Frech, Tracy, Molitor, Jerry A, Highland, Kristin, Read, Charles A, Fritzler, Marvin J, Kim, Grace Hyun J, Tseng, Chi-Hong, Elashoff, Robert M
Publicado no Lancet Respir Med (2016)